Recently, Gloria Pharmaceuticals says its wholly-owned subsidiaries Shenzheng Gloria investment in ￥56 million to set up Gloria Gene Biological Technology (Shenzhen) Co., Ltd. with Tianjin Hengzhi. This company will ..

Maverix Biomics and Diagnomics announced today that they have received CLIA validation for their next-generation sequencing pre-natal test on the Maverix Dx platform. The test, called Non-Invasive Chromosome Exam..

MDxHealth today announced a partnership with SouthGenetics to market its ConfirmMDx test for prostate cancer in Latin America. Under the terms of the agreement, Montevideo, Uruguay-based SouthGenetics secures r..

Recently, Endi Biology Technology Hebei Co., Ltd was approved to list on the new OTC market and public transfer. The note shows, Endi Biology’s revenues from January to June in 2015 is ￥4.184 million, an..

Core tip: GE announced its performance on Oct. 16 for Q3, while Philips announced it on Oct. 26. Siemens fiscal year is a bit of special starting from Oct. 1 ending to Sep. 30, so it announced on Nov. 12 was Q4 perfor..

Biotech giant Amgen recently announced that it has developed a strategic tumor immunology cooperation with Merck, which is another giant in the field of immunotherapy. The partners will jointly launch a Ib / III stud..

Thermo Scientific Prelude MD high performance liquid chromatography, Endura MD mass spectrometer and ClinQuan MD software of Thermo Fisher Scientific（Waltham，MA，USA have received CE mark. European clinical laborato..

Human Longevity Inc. (HLI) said today it has acquired Cypher Genomics for an undisclosed price, in a deal that adds human genomic interpretation software solutions to the buyer’s offerings. Located in San..

Global testing for infectious diseases has reached USD 16.8 Billion and the segment continues to expand from demand, growing infrastructure in emerging nations, and intense competition, according to a new healthcare m..

BG Medicine said today that it has amended its agreement with Abbott Laboratories for licensing and distributing its galectin-3 test. The amendment changes product fees Abbott pays to BG Medicine for galectin-3..

The US Food and Drug Administration (FDA) has granted clearance for Siemens Healthcare's Multitom Rax robotic advanced x-ray system.The new diagnostic imaging system offers a range of examinations in multiple clin..

Teva Pharmaceutical Industries and Heptares will collaborate to develop new Heptares-discovered small-molecule calcitonin gene-related peptide (CGRP) antagonists for migraine, the companies said today. The deal c..

According to MarketsandMarkets, the molecular diagnostics market is estimated to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020. In this report, the molecular diagnostics market is broadly segmente..

The US Food and Drug Administration (FDA) has approved EDDA Technology's new IQQA-Guide, an intra-operative precision 3D navigation system.IQQA-Guide is designed to provide intra-operative precision 3D navigation ..

Want to get noticed at work for all the good reasons and not the bad ones? This will help you achieve your career goals and feel recognized for your hard work. 2.Pay attention to your personal appearance. ..

Dutch molecular diagnostics firm SkylineDx today announced it has received CE-IVD certification for its MMprofiler. The test determines prognosis risk for multiple myeloma patients based on the SKY92 gene signatu..

Blood glucose monitor manufacturers are working to make their data easily accessible and analyzable by patients and healthcare providers. But that's a tall order for this industry segment, which has historically b..

St. Jude Medical announced FDA approval of the Proclaim Elite Spinal Cord Stimulation System to treat chronic back pain.It's the only recharge-free spinal cord stimulation system in its class, at least in the U.S...

GlaxoSmithKline ($GSK) is taking a gamble on Idera Pharmaceuticals' ($IDRA) antisense drug technology, promising up to $100 million in a collaboration focused on renal disease. Under the deal, GSK is paying it..

Vela Diagnostics today announced a collaboration with France's Gustave Roussy Institute of Oncology on next-generation based cancer testing. The collaboration will focus on both solid and liquid tumor diagn..